Open AccessAnti-PD1/PD-L1 monotherapy vs standard of care in patients with recurrent or metastatic head and neck squamous cell carcinoma
Author(s) -
Peng Zhu,
Yanwei Wang,
Wendi Zhang,
Xin Liu
Publication year - 2021
Publication title -
medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.59
H-Index - 148
eISSN - 1536-5964
pISSN - 0025-7974
DOI - 10.1097/md.0000000000024339
Subject(s) - medicine , hazard ratio , oncology , confidence interval , adverse effect , head and neck squamous cell carcinoma , randomized controlled trial , relative risk , meta analysis , head and neck cancer , cancer